A Cancer Vaccine Just Passed Its Biggest Test Yet — And It Could Be Bigger Than Melanoma
ABE NEWS | THURSDAY, AUGUST 20, 2026 For years, scientists have talked about a future where cancer treatment could be designed specifically for one person’s tumor. That future may have just moved significantly closer. Moderna and Merck announced that their experimental personalized mRNA cancer vaccine, intismeran, succeeded in a large Phase 3 trial involving…